EFFMED HEALTHCARE

1.ACHIEVED TURN OVER OF 25 LACS IN ONE YEAR,
2.OPERATING HIGHEST POTENTIAL GASTRO/ENT SEGMENT WITH HUGE MARKET SIZE OF >3000 CRORES IN UP ONLY ,
3.GOOD BRANDS WITH HIGH ACCEPTENCE
4. NEED FUNDING FOR MANPOWER EXPANSION,
5. PARTNERSHIP AS SUCH FIRM

1.Started on 28/10/2016 with 6 products (brands)
2.Targeting 300 doctors in Gastro, ENT, C.P. segment, in 4 towns of Uttar Pradesh-Lucknow, Kanpur, Gorakhpur, Faizabad,
3.More then 200000 patents seen by these doctors annually,
4. Having sales of $5000 monthly with operation profit of >50%,
5.Huge potential to expand to >1000 doctors with a million patients and markets size of $30 million

India is the largest market for pharma and has witnessed the tremendous growth of many companies like SUN Pharmaceuticals, Cadila, Cipla, Mankind, Eris which became giants after a very humble beginning , the second highly populated country in the world having ample scope for every company to grow and service humanity .

Providing low cost treatment to majority of ailing people will be true service as well as business prospect.

1. Huge population suffering from infectious and gastrointestinal deceases due to poor hygiene conditions, malnutrition, poverty, illiteracy, availability of proper health facilities and high cost of treatment.
2. Huge unemployment makes easy availability of workers and field force to build strong sales team,
3. Govt favoring industry generating employment,
4. Easily available raw material and finished goods at very competitive prices .

Our products are approved by USFDA and Indian Pharmacopoeia for treating various conditions and offers fast relief and effective treatment in various diseases which are very common in masses of INDIA.

They are most preferred drugs to be recommended by doctors

Many local, national and global pharma companies, and large number of brands,

Sun Pharma :
Zydus Cadila,
Abbott India,
Cipla,
Mankind,
are the largest but almost 12000 companies are operating in india .

1. Huge customer base opportunity to every one doing business
2. Excellent quality and reasonable prices are major driving force to highly price sensitive market
3. Excellent customer relation of promoters,
4. Wast experience and business contacts of promoters

We are selling 10% approx less price then main competitor brands,

Expected turnover in 5 years is a million $ per year with net profit as per following trend
1 Year ( 2018-2019) : Turn over: $150000 with PAT expected: $40000
2 Year (2019-2020): Turn over: $250000 with PAT expected: $80000,
3 Year (2020-2021): Turn over: $550000 with PAT expected: $120000,
4 Year (2021-2022): Turn over: $750000 with PAT expected: $200000,
5 Year (2022-2023):Turn over: $1000000 with PAT expected: $400000

Sales : Medical sales representatives to approach, inform , convince the doctors about our products ,

Distribution: Through Company warehouse >CFA>Stockist> Retail chemist>Patients
Payment realisation > within 1 month of billing from warehouse,

1. Expanding product range,
2. Increasing employees,
3. Promotional activities
4. Expanding infrastructure
5. Entering new markets

10% profit share,

Govt policies regarding heath services